|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:activeIngredient
|
gptkb:cyproterone_acetate
|
|
gptkbp:approvedBy
|
1973
|
|
gptkbp:ATCCode
|
gptkb:G03HA01
|
|
gptkbp:chemicalClass
|
progestin
steroidal antiandrogen
|
|
gptkbp:contraindication
|
gptkb:liver_disease
pregnancy
meningioma
|
|
gptkbp:eliminationHalfLife
|
1.6–4.3 days (oral)
3.3–13.3 days (IM)
|
|
gptkbp:form
|
tablets
injectable solution
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Androcur
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Bayer
|
|
gptkbp:marketedIn
|
gptkb:Australia
gptkb:Europe
|
|
gptkbp:mechanismOfAction
|
androgen receptor antagonist
progestogenic activity
|
|
gptkbp:pregnancyCategory
|
X
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular injection
|
|
gptkbp:sideEffect
|
gptkb:depression
fatigue
infertility
liver toxicity
gynecomastia
reduced libido
|
|
gptkbp:soldIn
|
gptkb:United_States
|
|
gptkbp:synonym
|
gptkb:cyproterone_acetate
|
|
gptkbp:usedFor
|
prostate cancer
transgender hormone therapy
hirsutism
hypersexuality
androgen-dependent conditions
precocious puberty
|
|
gptkbp:bfsParent
|
gptkb:Bayer_HealthCare
|
|
gptkbp:bfsLayer
|
6
|